A Double-Blind, Placebo-Controlled Trial to Assess Safety and Tolerability of (Thetanix) Bacteroides thetaiotaomicron in Adolescent Crohn's Disease

INTRODUCTION: Thetanix (gastroresistant capsules containing lyophilized Bacteroides thetaiotaomicron) is a live biotherapeutic, under development for Crohn's disease, that antagonizes transcription factor nuclear factor kappa B, reducing proinflammatory cytokines, particularly tumor necrosis fa...

Descripción completa

Detalles Bibliográficos
Autores principales: Hansen, Richard, Sanderson, Ian R., Muhammed, Rafeeq, Allen, Stephen, Tzivinikos, Christos, Henderson, Paul, Gervais, Lisa, Jeffery, Ian B., Mullins, David P., O'Herlihy, Eileen A., Weinberg, John D., Kitson, Geoff, Russell, Richard K., Wilson, David C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752678/
https://www.ncbi.nlm.nih.gov/pubmed/33464732
http://dx.doi.org/10.14309/ctg.0000000000000287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752678/
https://www.ncbi.nlm.nih.gov/pubmed/33464732
http://dx.doi.org/10.14309/ctg.0000000000000287

Ejemplares similares